About The Position

Johnson & Johnson is recruiting a Group Product Director for Precision Medicine, RYBREVANT, based in Horsham, Pennsylvania. The role is part of the US Oncology Precision Medicine Commercial team and is responsible for shaping and executing precision medicine strategies for current and future oncology brands, with primary alignment to the lung cancer franchise. The team supports the broader Solid Tumor and Hematology portfolios; this position leads the RYBREVANT portfolio (lung, colorectal cancer, and head and neck) and oncology portfolio-level precision medicine capabilities. The position partners closely with lung and pipeline brand teams, including the Therapeutic Area Leader Solid and Launch Readiness Teams, to align precision medicine strategies with brand priorities and disease-state, provider, and patient needs. Reporting to the Senior Director, US Oncology Precision Medicine, the role leads portfolio initiatives to enhance precision medicine capabilities and works cross-functionally with commercial, medical, policy, access, and field teams. The role may require up to 25% domestic travel.

Requirements

  • Bachelor’s degree.
  • At least 5 years of experience in marketing, sales, and/or Precision Medicine.
  • Prior experience in Precision Medicine, either directly or through a targeted therapy product.
  • Demonstrated ability to drive a culture of growth mindset and high performance expectations, and to create an environment of testing and learning.
  • Strong communication and collaboration skills.

Nice To Haves

  • MBA or advanced degree.
  • Experience in Oncology.
  • Demonstrated commitment to learning emerging technologies, such as AI, through exploration, iteration, and applying new tools over time.

Responsibilities

  • Build understanding of the patient testing journey, diagnostic landscape, and testing rates at national and sub-national levels in partnership with Commercial Excellence and brand teams.
  • Serve as the commercial subject matter expert on biomarkers, ensuring alignment across brand assets, messaging, and execution.
  • Collaborate with franchise, brand, and field teams to identify and address account-level precision medicine needs aligned with strategic priorities.
  • Partner with Policy and Access teams to support broad access to guideline-concordant testing across the Janssen oncology portfolio.
  • Partner with lung and pipeline brand teams to develop and execute precision medicine strategies aligned with brand priorities.
  • Lead unbranded biomarker awareness and testing initiatives for healthcare practitioners, pathologists, and other key stakeholders.
  • Develop and maintain an integrated US Precision Medicine external communications strategy, including digital engagement and congress presence.
  • Lead portfolio initiatives to enhance precision medicine capabilities across the organization.
© 2026 Teal Labs, Inc
Privacy PolicyTerms of Service